These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D. Boettler T, von Herrath M. Int Immunopharmacol; 2010 Dec; 10(12):1491-5. PubMed ID: 20667487 [Abstract] [Full Text] [Related]
5. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes. Zhao Y, Lin B, Dingeldein M, Guo C, Hwang D, Holterman MJ. Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575 [Abstract] [Full Text] [Related]
6. Immunotherapy for the prevention and treatment of type 1 diabetes. Goudy KS, Tisch R. Int Rev Immunol; 2005 May; 24(5-6):307-26. PubMed ID: 16318984 [Abstract] [Full Text] [Related]
7. Beta-cell replacement for insulin-dependent diabetes mellitus. Efrat S. Adv Drug Deliv Rev; 2008 Jan 14; 60(2):114-23. PubMed ID: 18022276 [Abstract] [Full Text] [Related]
18. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation. Khadra A, Santamaria P, Edelstein-Keshet L. J Theor Biol; 2009 Jan 07; 256(1):126-41. PubMed ID: 18950644 [Abstract] [Full Text] [Related]
20. The potential role of dendritic cells in the therapy of Type 1 diabetes. Lee CN, Lew AM, Wu L. Immunotherapy; 2013 Jun 07; 5(6):591-606. PubMed ID: 23725283 [Abstract] [Full Text] [Related] Page: [Next] [New Search]